These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24982681)

  • 1. A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism.
    Shah S; Forghani N; Durham E; Neely EK
    Int J Pediatr Endocrinol; 2014; 2014(1):12. PubMed ID: 24982681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS.
    Raz L; Hunter LV; Dowling NM; Wharton W; Gleason CE; Jayachandran M; Anderson L; Asthana S; Miller VM
    Climacteric; 2016; 19(1):49-59. PubMed ID: 26652904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial.
    Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Lowe VJ; Fields JA; Gunter JL; Senjem ML; Settell ML; Gleason CE; Shuster LT; Bailey KR; Dowling NM; Asthana S; Jack CR; Rocca WA; Miller VM
    Neurology; 2018 Apr; 90(16):e1404-e1412. PubMed ID: 29661902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of changes in biochemical markers of bone turnover after 6 months of hormone replacement therapy with either transdermal 17 beta-estradiol or equine conjugated estrogen plus nomegestrol acetate].
    Collette J; Viethel P; Dethor M; Chevallier T; Micheletti MC; Foidart JM; Reginster JY
    Gynecol Obstet Fertil; 2003 May; 31(5):434-41. PubMed ID: 14567121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of menopausal hormone therapy on proteins associated with senescence and inflammation.
    Faubion L; White TA; Peterson BJ; Geske JR; LeBrasseur NK; Schafer MJ; Mielke MM; Miller VM
    Physiol Rep; 2020 Aug; 8(16):e14535. PubMed ID: 32857481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
    Prestwood KM; Kenny AM; Kleppinger A; Kulldorff M
    JAMA; 2003 Aug; 290(8):1042-8. PubMed ID: 12941676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
    Casanova G; Spritzer PM
    Lipids Health Dis; 2012 Oct; 11():133. PubMed ID: 23046709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is There a Difference between Ultrasonographic (US) Uterine Changes of Oral Versus Transdermal (TD) 17β Estradiol (17β E2) in Girls with Turner Syndrome (TS)? Own Experience and Literature Review.
    Kraus J; Unanue N; Espinoza A; Iniguez G; Torres-Santiago L; Singh R; Mauras N; Mericq V
    Pediatr Endocrinol Rev; 2018 Sep; 16(1):178-185. PubMed ID: 30371036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome.
    Torres-Santiago L; Mericq V; Taboada M; Unanue N; Klein KO; Singh R; Hossain J; Santen RJ; Ross JL; Mauras N
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2716-24. PubMed ID: 23678038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
    Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
    Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
    Nelson HD
    JAMA; 2004 Apr; 291(13):1610-20. PubMed ID: 15069049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets.
    Raz L; Hunter LW; Jayachandran M; Heit JA; Miller VM
    Physiol Rep; 2014; 2(3):e00275. PubMed ID: 24760527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial.
    Misra M; Katzman DK; Estella NM; Eddy KT; Weigel T; Goldstein MA; Miller KK; Klibanski A
    J Clin Psychiatry; 2013 Aug; 74(8):e765-71. PubMed ID: 24021517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.